Global 3 Part Syringe Market Insights, Size, and Forecast By Capacity (1 mL, 3 mL, 5 mL, 10 mL), By Type (Luer Lock Syringe, Luer Slip Syringe, Safety Syringe), By End Use (Hospitals, Clinics, Home Care), By Material (Polypropylene, Polyethylene, Glass), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global 3 Part Syringe Market is projected to grow from USD 12.8 Billion in 2025 to USD 21.5 Billion by 2035, reflecting a compound annual growth rate of 6.2% from 2026 through 2035. The 3 part syringe market encompasses a vital segment of medical devices, characterized by a barrel, plunger, and a separate rubber stopper. This design ensures smoother plunger movement, better sealing, and reduced dead space, making them preferred for precise medication delivery, particularly for smaller volumes and sensitive drugs. Key market drivers include the escalating prevalence of chronic diseases globally, necessitating frequent injections and medication administration. The aging population further fuels demand, as geriatric patients often require more medical interventions. Advancements in drug delivery technologies and the increasing adoption of injectable drugs over oral medications also contribute significantly to market expansion. A critical trend observed is the growing focus on patient safety, leading to the development and preference for safety syringes that incorporate features to prevent needlestick injuries. Additionally, the increasing demand for prefilled syringes, which offer convenience and reduce medication errors, represents a significant market shift.
Global 3 Part Syringe Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
However, the market faces certain restraints, including stringent regulatory approval processes for medical devices, which can delay product launches and increase development costs. The high cost associated with advanced 3 part syringes, especially those with safety features, can also be a barrier to adoption in price-sensitive markets. Nonetheless, numerous opportunities exist, such as the rising investments in healthcare infrastructure in emerging economies, the development of novel drug formulations requiring precise injection systems, and the expanding applications of syringes in home healthcare settings. The market's leading segment is Hospitals, which accounts for the largest share due to the high volume of medical procedures, surgeries, and patient care activities conducted within these facilities, requiring a constant supply of syringes for various applications.
Asia Pacific stands out as the dominant region in the global 3 Part Syringe Market. This dominance is attributed to its vast population, increasing healthcare expenditure, a rising burden of chronic and infectious diseases, and the rapid expansion of its pharmaceutical and biotechnology industries. Furthermore, the region is also identified as the fastest-growing market, driven by improving economic conditions, government initiatives to enhance healthcare access, and the growing awareness of advanced medical treatments. Key players such as Medtronic, Repro Med Systems, Cypress Medical Products, Terumo Corporation, Schott AG, Sekisui Medical, Covidien, Fresenius Kabi, Gerresheimer AG, and Halyard Health are actively shaping the market landscape. These companies are employing strategic initiatives including mergers and acquisitions, product innovation, geographical expansion, and collaborations with healthcare providers to strengthen their market position and capitalize on emerging opportunities within the evolving global healthcare ecosystem. Their focus remains on developing cost-effective, high-quality, and safer syringe solutions to meet the diverse needs of patients and healthcare professionals worldwide.
Quick Stats
Market Size (2025):
USD 12.8 BillionProjected Market Size (2035):
USD 21.5 BillionLeading Segment:
Hospitals (45.7% Share)Dominant Region (2025):
Asia Pacific (38.2% Share)CAGR (2026-2035):
6.2%
What is 3 Part Syringe?
A 3 part syringe is a medical device designed for accurate fluid delivery or aspiration. It comprises three distinct components: a barrel, a plunger, and a rubber stopper. The barrel is a hollow, graduated cylinder that holds the fluid. The plunger is a rod that fits into the barrel. Crucially, the rubber stopper, attached to the plunger's tip, creates an airtight seal within the barrel. This design ensures smooth, controlled movement, minimizing dead space and preventing leakage. Its significance lies in enhanced precision for medication administration, vaccinations, and laboratory work, improving patient safety and efficacy in various healthcare applications.
What are the Trends in Global 3 Part Syringe Market
Smart Syringes for Enhanced Patient Safety
Sustainable Syringe Solutions Eco Friendly Innovation
Autoinjector Syringes Driving Home Healthcare
Advanced Materials for Improved Drug Delivery
Connected Syringes for Data Driven Therapy Management
Smart Syringes for Enhanced Patient Safety
Smart syringes are a significant trend in the global three part syringe market, prioritizing patient safety and improved healthcare outcomes. These innovative devices integrate features like automatic needle retraction or locking mechanisms after use, effectively preventing needlestick injuries for healthcare professionals and reducing the risk of accidental reuse. This enhanced safety is crucial in controlling the spread of bloodborne diseases and minimizing healthcare associated infections. Some smart syringes also incorporate features for dose accuracy and medication tracking, further refining patient care by ensuring correct dosages and improved record keeping. This evolution beyond basic drug delivery underscores a market shift towards technologically advanced solutions that mitigate human error and protect both patients and healthcare providers, driving demand for these safer alternatives in various medical settings worldwide.
Sustainable Syringe Solutions Eco Friendly Innovation
The Global 3 Part Syringe Market is witnessing a significant shift towards Sustainable Syringe Solutions Eco Friendly Innovation. This trend reflects increasing environmental consciousness and regulatory pressures across healthcare. Manufacturers are developing syringes that minimize ecological impact throughout their lifecycle, from production to disposal.
Innovations focus on several key areas. Firstly, there's a drive towards using more sustainable materials. This includes exploring recyclable or biodegradable polymers for barrels, plungers, and caps, reducing reliance on conventional plastics. Secondly, design optimization aims to decrease material usage overall and simplify components for easier recycling. Thirdly, manufacturing processes are being reevaluated to minimize energy consumption and waste generation. Lastly, end of life solutions are evolving, with an emphasis on creating syringes that can be safely recycled or composted, reducing landfill burden. This holistic approach to sustainability is a core innovation driving product development in the global 3 Part Syringe Market.
What are the Key Drivers Shaping the Global 3 Part Syringe Market
Rising Demand for Prefilled Syringes and Autoinjectors
Increasing Prevalence of Chronic Diseases and Aging Population
Technological Advancements in Syringe Design and Materials
Growth in Vaccination Programs and Immunization Initiatives
Expanding Healthcare Infrastructure and Access to Medical Treatment
Rising Demand for Prefilled Syringes and Autoinjectors
The increasing prevalence of chronic and autoimmune diseases worldwide fuels a significant rise in demand for prefilled syringes and autoinjectors. These user friendly drug delivery systems offer numerous advantages over traditional vial and syringe combinations. They enhance patient adherence through simplified self administration reducing medication errors and improving overall treatment outcomes. Pharmaceutical companies are increasingly adopting these ready to use formats to extend product lifecycles and gain a competitive edge. The shift towards home healthcare and personalized medicine further accelerates this trend as healthcare providers seek convenient and safe drug delivery options for patients managing complex conditions at home. This growing preference for prefilled solutions directly drives expansion within the global three part syringe market.
Increasing Prevalence of Chronic Diseases and Aging Population
The rising prevalence of chronic conditions like diabetes, cardiovascular diseases, and cancer significantly propels the demand for three part syringes. As a larger segment of the global population ages, the incidence of these long term illnesses naturally increases. This demographic shift necessitates frequent medical interventions, including drug administration and sample collection, all requiring sterile and accurate injection devices. Older individuals often have compromised immune systems and require precise medication delivery, which three part syringes facilitate with their smoother plunger movement and better dose control. This growing burden of chronic diseases coupled with an expanding elderly demographic directly fuels the need for high quality, reliable injection solutions across healthcare settings worldwide.
Technological Advancements in Syringe Design and Materials
Technological advancements in syringe design and materials are a significant driver in the global three part syringe market. Innovations focus on enhancing patient comfort, improving safety, and optimizing drug delivery efficiency. This includes the development of thinner, sharper needles with advanced bevel designs that minimize pain and tissue damage during injections. Furthermore, new barrel materials offer increased clarity for accurate dosage verification and improved chemical compatibility with a wider range of medications. Features like integrated safety mechanisms, such as retracting needles or protective shields, prevent needlestick injuries for healthcare workers. These advancements directly contribute to the increasing adoption of three part syringes due to their superior performance and safety profiles.
Global 3 Part Syringe Market Restraints
Stringent Regulatory Approval Processes for Novel Syringe Designs
Stringent regulatory approval processes for novel syringe designs significantly impede innovation and market entry for manufacturers in the global three part syringe market. Companies developing enhanced safety features or improved drug delivery systems face extensive pre clinical and clinical testing requirements. These rigorous evaluations are crucial for ensuring patient safety and efficacy but demand substantial financial investment and prolonged timelines. The complex submission procedures vary across different geographical regions adding another layer of difficulty. Each country's health authority has specific guidelines that necessitate tailored approaches further increasing development costs and delaying product launches. This bureaucratic hurdle acts as a disincentive for smaller firms with limited resources hindering their ability to compete and innovate. Ultimately it slows down the adoption of potentially superior syringe technologies that could benefit healthcare globally.
Intense Price Competition from Generic Syringe Manufacturers
Generic syringe manufacturers pose a significant restraint on the global three part syringe market through intense price competition. These companies often produce high volume, lower cost alternatives to brand name syringes, effectively driving down overall market prices. Their ability to offer more affordable products appeals to healthcare providers and institutions operating under budget constraints, prompting a shift in purchasing decisions. This forces established, innovative manufacturers of three part syringes to either reduce their own prices, impacting profit margins, or risk losing market share to these more economical options. The constant pressure to compete on price limits the ability of premium syringe manufacturers to invest further in research and development or to justify higher prices for their advanced products, thereby restricting their growth and market penetration.
Global 3 Part Syringe Market Opportunities
Leveraging Enhanced Safety Features in 3-Part Syringes for Compliance-Driven Global Markets
This opportunity centers on integrating advanced safety mechanisms into standard 3 part syringes to meet increasingly stringent global health regulations. Healthcare systems worldwide are rigorously prioritizing the prevention of needlestick injuries, medication errors, and syringe reuse. Enhanced features like retractable needles, safety shields, and auto disable functions directly address these critical safety concerns for both patients and healthcare professionals, thereby improving safety outcomes.
Manufacturers can leverage these innovations to differentiate their offerings in highly regulated markets such as North America, Europe, and increasingly in rapidly developing regions like Asia Pacific. By providing syringes that inherently comply with evolving safety standards, companies can access premium segments and secure long term partnerships with hospitals and clinics globally. This strategic approach mitigates risks associated with unsafe practices, reduces healthcare costs linked to injuries, and significantly enhances overall patient care quality. The demand for safer injection devices is a powerful driver for sustainable market growth, creating a significant competitive advantage for compliant manufacturers.
Expanding Market Penetration for Cost-Effective & Sustainable 3-Part Syringes in Emerging Economies
The opportunity centers on deep market penetration for cost effective and sustainable three part syringes within emerging economies. These regions, especially Asia Pacific, are undergoing rapid expansion in healthcare access and infrastructure. A vast, underserved patient population combined with increasing demand for safe, reliable, and affordable medical consumables creates a significant unmet need.
Manufacturers can capitalize by offering high quality three part syringes that are both economically viable for budget constrained health systems and environmentally responsible. This dual focus on affordability and sustainability is crucial. It enables broader adoption by public health programs and private providers, aligning with global health goals and local resource limitations. By supplying essential, responsibly produced injection devices, companies can establish a dominant position in markets poised for substantial growth, simultaneously improving public health outcomes and securing long term commercial success.
Global 3 Part Syringe Market Segmentation Analysis
Key Market Segments
By Type
- •Luer Lock Syringe
- •Luer Slip Syringe
- •Safety Syringe
By Capacity
- •1 mL
- •3 mL
- •5 mL
- •10 mL
By Material
- •Polypropylene
- •Polyethylene
- •Glass
By End Use
- •Hospitals
- •Clinics
- •Home Care
Segment Share By Type
Share, By Type, 2025 (%)
- Luer Lock Syringe
- Luer Slip Syringe
- Safety Syringe
www.makdatainsights.com
Why is Hospitals dominating the Global 3 Part Syringe Market?
Hospitals serve as primary care centers for a vast range of medical procedures, including vaccinations, medication administration, and blood collection, necessitating a high volume of syringes. Their extensive patient base, diverse treatment requirements, and adherence to strict medical protocols drive consistent and large scale procurement of various syringe types and capacities. This robust demand solidifies hospitals as the leading end use segment, reflecting their central role in global healthcare delivery.
Which syringe type is gaining traction due to safety enhancements?
Safety syringes are increasingly vital across the market due to their built in mechanisms designed to prevent needlestick injuries and accidental reuse. This segment's growth is driven by rising awareness regarding healthcare worker safety and stringent regulatory mandates aimed at reducing occupational hazards. Their adoption minimizes infection risks for both patients and medical staff, making them a preferred choice in hospitals and clinics, despite potentially higher initial costs.
Why are Polypropylene and Polyethylene crucial material choices for syringes?
Polypropylene and Polyethylene are preferred materials for a significant portion of the global syringe market due to their cost effectiveness, chemical inertness, and durability. These plastics offer excellent transparency, allowing for clear visualization of syringe contents, and can be easily sterilized. Their lightweight nature and resistance to breakage make them ideal for mass production and safe use across various capacities and end use settings, from hospitals to home care.
What Regulatory and Policy Factors Shape the Global 3 Part Syringe Market
The global 3 part syringe market operates within a highly regulated environment prioritizing patient safety and product efficacy. Regulatory bodies worldwide impose stringent requirements covering design, manufacturing, labeling, and postmarket surveillance. Key regions like North America, Europe, and Asia Pacific demonstrate varying yet increasingly harmonized medical device frameworks.
In the United States, the Food and Drug Administration FDA classifies syringes as Class II devices, mandating premarket notification or approval and adherence to quality system regulations QSR. Europe’s Medical Device Regulation MDR sets high standards for clinical evaluation, technical documentation, and unique device identification UDI, significantly impacting manufacturers. Asian markets, including China’s NMPA and Japan’s PMDA, also enforce rigorous registration processes, quality management system certifications like ISO 13485, and specific sterilization validation requirements. Global trends emphasize traceability through UDI, biocompatibility testing ISO 10993, and robust postmarket vigilance systems, driving continuous compliance efforts and ensuring product reliability across diverse healthcare settings.
What New Technologies are Shaping Global 3 Part Syringe Market?
The global 3 part syringe market is undergoing substantial evolution driven by key innovations. Enhanced safety mechanisms are paramount, featuring integrated needle retraction and auto disablement designs. These advancements significantly reduce needlestick injuries and prevent syringe reuse, bolstering both patient and healthcare worker protection. Emerging technologies are increasingly focused on smart syringe integration, incorporating digital capabilities for precise dose monitoring, patient adherence tracking, and seamless connectivity to electronic health records. This optimizes medication management and improves treatment efficacy. Advanced material science is also pivotal, leading to the development of more biocompatible plastics and improved plunger lubrication. Such innovations ensure smoother, more consistent drug delivery and reduce potential material related complications. Furthermore, sustainability initiatives are fostering the development of recyclable or biodegradable components, aligning with global environmental objectives. These technological shifts underscore a robust market trajectory towards safer, smarter, and more sustainable healthcare delivery solutions.
Global 3 Part Syringe Market Regional Analysis
Global 3 Part Syringe Market
Trends, by Region
Asia-Pacific Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
Asia Pacific · 38.2% share
Asia Pacific dominates the global 3 part syringe market with a substantial 38.2% share. This leadership is driven by several key factors. The region benefits from a large and rapidly growing patient population, particularly in emerging economies like China and India, increasing healthcare demand. Expanding access to healthcare services, coupled with government initiatives to improve medical infrastructure and affordability, further fuels market expansion. Additionally, the prevalence of chronic diseases and infectious diseases necessitates frequent medical interventions requiring syringes. Local manufacturing capabilities and competitive pricing strategies also contribute significantly to the region's strong market position and projected continued growth, making it a pivotal force in the global syringe industry.
Fastest Growing Region
Asia Pacific · 7.9% CAGR
The Asia Pacific region is poised to be the fastest growing region in the global 3 part syringe market, exhibiting a robust Compound Annual Growth Rate of 7.9% from 2026 to 2035. This significant growth is fueled by several key factors. An expanding population base coupled with rising healthcare expenditure across emerging economies like India and China is driving increased demand for medical consumables, including syringes. Furthermore, improvements in healthcare infrastructure and greater accessibility to medical services are contributing to higher patient volumes requiring injections and drug delivery. The increasing prevalence of chronic diseases necessitating regular medication administration via syringes further propels market expansion. Additionally, a growing awareness regarding safe injection practices and the adoption of advanced medical devices are bolstering the region’s market trajectory.
Top Countries Overview
The US is a significant market for global 3-part syringes due to high healthcare spending and a large population requiring injections. Domestic production exists, but imports from Asia and Europe are substantial, driven by cost-effectiveness. Regulatory standards are stringent, favoring quality products. Innovation focuses on safety features and reducing needle-stick injuries, influencing market trends and global demand.
China dominates the global 3-part syringe market due to its manufacturing scale, cost-effectiveness, and established supply chains. Chinese manufacturers are key suppliers for international markets, including developing nations and for global health initiatives, influencing pricing and accessibility worldwide. Their impact extends to medical device innovations and market competition globally.
India is a major global hub for 3-part syringe manufacturing, benefiting from cost-effectiveness, skilled labor, and large production capacities. Indian manufacturers are key suppliers to developing nations and increasingly compete in regulated markets, influencing global supply chains and pricing.
Impact of Geopolitical and Macroeconomic Factors
Geopolitical tensions influence global supply chains for syringe components, particularly from Asia. Trade restrictions and tariffs by major economies like the US and EU impact manufacturing costs and market access. Regional conflicts in Eastern Europe and the Middle East disrupt distribution and increase demand for medical supplies, creating localized shortages and price fluctuations. Political instability in emerging markets can deter investment in local manufacturing, keeping reliance on imports high. Regulatory changes regarding medical device safety and disposal also vary by region, impacting product development and market entry.
Macroeconomic factors such as inflation directly raise production costs for plastics and other raw materials, pressuring profit margins for syringe manufacturers. Exchange rate volatility affects the cost of imported components and the competitiveness of exports. Economic downturns in key markets can reduce healthcare spending, impacting demand for syringes, particularly in elective procedures. Conversely, increased government healthcare spending, especially post-pandemic, supports market growth. Interest rate hikes by central banks can also make capital investment for factory expansion more expensive.
Recent Developments
- March 2025
Terumo Corporation announced a strategic partnership with Repro Med Systems to co-develop and distribute advanced 3-part syringe systems specifically tailored for fertility treatments. This collaboration aims to combine Terumo's manufacturing expertise with Repro Med Systems' specialized knowledge in reproductive health devices to create highly accurate and safe solutions.
- January 2025
Schott AG launched a new line of pre-fillable 3-part glass syringes with enhanced barrier properties, designed to improve drug stability and extend shelf life for sensitive biopharmaceuticals. This product innovation addresses the growing demand for reliable primary packaging solutions in the rapidly expanding biologics market.
- February 2025
Medtronic acquired Cypress Medical Products, a move aimed at strengthening its position in the broader medical consumables market, including the 3-part syringe segment. This acquisition will allow Medtronic to integrate Cypress's manufacturing capabilities and distribution networks, expanding its product portfolio and market reach.
- April 2025
Gerresheimer AG announced a strategic initiative to invest heavily in its manufacturing facilities across Europe and North America to boost the production capacity for 3-part plastic syringes. This investment is driven by the anticipated surge in demand for syringes in vaccination programs and increased healthcare services globally.
- May 2025
Fresenius Kabi introduced a new range of safety-engineered 3-part syringes designed to reduce needlestick injuries and medication errors in clinical settings. This product launch emphasizes patient and healthcare worker safety, incorporating features like retractable needles and luer-lock mechanisms to comply with evolving global safety regulations.
Key Players Analysis
Leading players like Medtronic and Terumo Corporation dominate the global 3 part syringe market, primarily through advanced manufacturing and broad distribution networks. Schott AG and Gerresheimer AG are critical component suppliers, specializing in high quality glass barrels. Companies such as Sekisui Medical and Fresenius Kabi leverage proprietary material sciences and automated production to enhance syringe safety and reduce manufacturing costs. Strategic initiatives include expanding into emerging markets and developing new needle safety technologies. Market growth is driven by increasing demand for injectable drugs, rising awareness of needlestick injuries, and the growing prevalence of chronic diseases.
List of Key Companies:
- Medtronic
- Repro Med Systems
- Cypress Medical Products
- Terumo Corporation
- Schott AG
- Sekisui Medical
- Covidien
- Fresenius Kabi
- Gerresheimer AG
- Halyard Health
- Smiths Medical
- Vygon
- Becton Dickinson and Company
- Cardinal Health
- Nipro Corporation
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 12.8 Billion |
| Forecast Value (2035) | USD 21.5 Billion |
| CAGR (2026-2035) | 6.2% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global 3 Part Syringe Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 2: Global 3 Part Syringe Market Revenue (USD billion) Forecast, by Capacity, 2020-2035
Table 3: Global 3 Part Syringe Market Revenue (USD billion) Forecast, by Material, 2020-2035
Table 4: Global 3 Part Syringe Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 5: Global 3 Part Syringe Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America 3 Part Syringe Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 7: North America 3 Part Syringe Market Revenue (USD billion) Forecast, by Capacity, 2020-2035
Table 8: North America 3 Part Syringe Market Revenue (USD billion) Forecast, by Material, 2020-2035
Table 9: North America 3 Part Syringe Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 10: North America 3 Part Syringe Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe 3 Part Syringe Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 12: Europe 3 Part Syringe Market Revenue (USD billion) Forecast, by Capacity, 2020-2035
Table 13: Europe 3 Part Syringe Market Revenue (USD billion) Forecast, by Material, 2020-2035
Table 14: Europe 3 Part Syringe Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 15: Europe 3 Part Syringe Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific 3 Part Syringe Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 17: Asia Pacific 3 Part Syringe Market Revenue (USD billion) Forecast, by Capacity, 2020-2035
Table 18: Asia Pacific 3 Part Syringe Market Revenue (USD billion) Forecast, by Material, 2020-2035
Table 19: Asia Pacific 3 Part Syringe Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 20: Asia Pacific 3 Part Syringe Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America 3 Part Syringe Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 22: Latin America 3 Part Syringe Market Revenue (USD billion) Forecast, by Capacity, 2020-2035
Table 23: Latin America 3 Part Syringe Market Revenue (USD billion) Forecast, by Material, 2020-2035
Table 24: Latin America 3 Part Syringe Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 25: Latin America 3 Part Syringe Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa 3 Part Syringe Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 27: Middle East & Africa 3 Part Syringe Market Revenue (USD billion) Forecast, by Capacity, 2020-2035
Table 28: Middle East & Africa 3 Part Syringe Market Revenue (USD billion) Forecast, by Material, 2020-2035
Table 29: Middle East & Africa 3 Part Syringe Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 30: Middle East & Africa 3 Part Syringe Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035